BioSpace News Archive

Press Releases

Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting

March 19, 2026
·
2 min read
Press Releases

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026

March 19, 2026
·
3 min read
Press Releases

Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2025 Financial Results

March 19, 2026
·
34 min read
Press Releases

TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million

March 19, 2026
·
13 min read
Press Releases

Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson’s Disease Study

March 19, 2026
·
5 min read
Press Releases

CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-Pathology

March 19, 2026
·
12 min read
Press Releases

Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting

March 19, 2026
·
11 min read
Press Releases

Soligenix Announces HyBryte™ Clinical Summary Published in “Expert Opinion on Investigational Drugs”

March 19, 2026
·
16 min read
Press Releases

Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

March 19, 2026
·
14 min read
Press Releases

Lilly’s triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes

March 19, 2026
·
8 min read